• Mashup Score: 1

    The biological determinants of the response to immune checkpoint blockade (ICB) in cancer remain incompletely understood. Little is known about dynamic biological events that underpin therapeutic efficacy due to the inability to frequently sample tumours in patients. Here, we map the transcriptional profiles of 144 responding and non-responding tumours within two mouse models at four time points…

    Tweet Tweets with this article
    • 1/3 Just out in @NatureComms https://t.co/XPPyuDPFzK Temporally restricted activation of IFNβ signaling underlies response to immune checkpoint therapy in mice. Using mouse models to map the transcriptional profiles of responding and non responding #tumours in two mouse models

  • Mashup Score: 0

    Since its first proposal in the treatment of pituitary tumours more than a century ago, indications for cranial radiotherapy have notably evolved. In rare pituitary carcinomas, indication of radiotherapy remains undisputable after surgical treatment in case of remnant tumour or recurrence. Until the availability of effective medical treatment, radiotherapy was the second-line treatment for many…

    Tweet Tweets with this article
    • Luigi Maione & Philippe Chanson comment: Second #brain #tumours after #pituitary #irradiation: lower risk than once thought https://t.co/5l227CQmD6 #FREE to read with registration (also FREE) https://t.co/Odol29Li7n

  • Mashup Score: 1

    Since its first proposal in the treatment of pituitary tumours more than a century ago, indications for cranial radiotherapy have notably evolved. In rare pituitary carcinomas, indication of radiotherapy remains undisputable after surgical treatment in case of remnant tumour or recurrence. Until the availability of effective medical treatment, radiotherapy was the second-line treatment for many…

    Tweet Tweets with this article
    • Luigi Maione & Philippe Chanson comment: Second #brain #tumours after #pituitary #irradiation: lower risk than once thought https://t.co/5l227CQmD6 #FREE to read with registration (also FREE) https://t.co/1zvZYC0qUj

  • Mashup Score: 0

    Since its first proposal in the treatment of pituitary tumours more than a century ago, indications for cranial radiotherapy have notably evolved. In rare pituitary carcinomas, indication of radiotherapy remains undisputable after surgical treatment in case of remnant tumour or recurrence. Until the availability of effective medical treatment, radiotherapy was the second-line treatment for many…

    Tweet Tweets with this article
    • Comment by Luigi Maione & Philippe Chanson: Second #brain #tumours after #pituitary #irradiation: lower risk than once thought https://t.co/5l227CQmD6 #FREE to read with registration (also FREE) https://t.co/uSdE6YRTqK

  • Mashup Score: 0

    Since its first proposal in the treatment of pituitary tumours more than a century ago, indications for cranial radiotherapy have notably evolved. In rare pituitary carcinomas, indication of radiotherapy remains undisputable after surgical treatment in case of remnant tumour or recurrence. Until the availability of effective medical treatment, radiotherapy was the second-line treatment for many…

    Tweet Tweets with this article
    • Luigi Maione & Philippe Chanson comment: Second #brain #tumours after #pituitary #irradiation: lower risk than once thought https://t.co/5l227CQmD6 #FREE to read with registration (also FREE)

  • Mashup Score: 0

    Since its first proposal in the treatment of pituitary tumours more than a century ago, indications for cranial radiotherapy have notably evolved. In rare pituitary carcinomas, indication of radiotherapy remains undisputable after surgical treatment in case of remnant tumour or recurrence. Until the availability of effective medical treatment, radiotherapy was the second-line treatment for many…

    Tweet Tweets with this article
    • Also read the Linked Comment: Second #brain #tumours after #pituitary #irradiation: lower risk than once thought https://t.co/5l227CQmD6 #FREE to read with registration (also FREE)

  • Mashup Score: 4

    The impact of germline variants on somatic alterations in cancer remains to be explored in large-scale datasets. Here, the authors study the association of rare germline variants with somatic mutational processes in more than 15,000 tumors, and reveal that damaging variants in newly-identifed genes are prevalent in the population.

    Tweet Tweets with this article
    • Study of rare #germline variants in more than 15,000 #tumours reveals their impact on #somatic mutational processes and their prevalence in the population #CancerResearch by @Mischan11 @FranSupek @BenLehner @CRGenomica @IRBBarcelona @natrescancer https://t.co/LTKLi1NCQt https://t.co/9LQhNOobbq